SEC Form 4 · accession 0001140361-16-090412
CYTRX CORP · CYTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven A Kriegsman
Officer — CEO · Director · Other
Period of report
Dec 15, 2016
Accepted (ET)
Dec 20, 2016 · 7:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000799698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2016 | A | 2,325,581 | $0.43 | A | 2,325,581 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.43 | Dec 15, 2016 | A | 1,250,000 | A | — | Dec 14, 2026 | CytRx Common Stock | 1,250,000 | 1,250,000 | D |
Explanation of responses
- F1On Dec. 13, 2016, the Compensation Committee of the Board of Directors awarded to Mr. Kriegsman under the 2008 Equity Incentive Plan $1,000,000 of restricted shares of CytRx Common stock at the stock's closing price on Dec. 15, 2016. The restricted shares will vest in equal installments on the first three anniversaries of the award date, contingent upon his continuous employment through the applicable vesting date.
- F2The stock option vests monthly for 36 months in equal installments, beginning 15 January 2017, provided Reporting Person remains in continuous employ of Issuer, or the conditions for immediate vesting do not occur.